
 


| Course: |
Internal Medicine 1612
|
| Target Audience: |
| This activity is intended for the internist and family practitioner. |
| Sponsor: |
| This activity is sponsored by AHC Media. |
| Accreditation: |
| AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
| Credit Designation: |
AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/11. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue. |
| Faculty |
Editor
Stephen A. Brunton, MD
Clinical Professor
University of California, Irvine
Executive Editor
Leslie Coplin
Managing Editor
Neill Kimball
Associate Editors
Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine
UCLA School of Medicine
Michael H. Crawford, MD
Professor of Medicine
University of California, San Francisco
Chief of Clinical Cardiology
University of California
San Francisco Medical Center
Joseph E. Scherger, MD, MPH
Vice President, Primary Care
Eisenhower Medical Center
Clinical Professor
Keck School of Medicine
University of Southern California
William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco
James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA
Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville
Author
Susan T. Marcolina, MD, FACP
Internist and Geriatrician, Issaquah, WA
Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY
|
| Subjects: |
- Looks Like the Ear Lobe Crease is Here to Stay
- Use With Caution — Dangers of Common Antibiotics
- Soda and Stroke Risk: A Pop Connection?
- Tazarotene Foam, 0.1% (Fabior™)
- Clinical Briefs
|
| Objectives: |
- describe new findings in differential diagnosis and treatment of various diseases
- describe controversies, advantages, and disadvantages of those advances
- describe cost-effective treatment regimens
- describe the pros and cons of new screening procedures.
|
| Financial Disclosure: |
Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Lilly, Boehringer Ingelheim, Novo Nordisk, Sunovion, and Teva; he serves on the speakers bureau of Boehringer Ingelheim, Lilly, Kowa, Novo Nordisk, and Teva. Associate editors Harold L. Karpman, MD, FACC, FACP, Joseph E. Scherger, MD, MPH, author Susan T. Marcolina, MD, FACP, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD, peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study. Associate editor Louis Kuritzky, MD is an advisor for Endo, Kowa, Pricara, and Takeda.
Copyright 2012 AHC Media LLC. All rights reserved.
|
- You are not currently logged in.
- To view content articles and complete the post-test for this course, please login or register now
|
|